Brigit Biofarmaka Teknologi Tbk. vs Trust Finance Indonesia Tbk — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Trust Finance Indonesia Tbk trades at Rp426 (market cap 355.2B, 375.8K 24h volume). The key difference: Trust Finance Indonesia Tbk is far larger — about 2.1× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (592.2K versus 375.8K). Which is the better fit depends on your goals.
| OBAT | TRUS | |
|---|---|---|
Market Cap | 172.82B | 355.2B |
Volume | 592.2K | 375.8K |
Lot | 5.92K | 3.76K |
Turnover | 147.05M | 159.5M |
Average Price | 248.31 | 424.44 |
Value | 147.05M | 159.5M |
Indicative Equilibrium Price | 254 | 426 |
Indicative Equilibrium Volume | 10 | 6 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Trust Finance Indonesia Tbk (the Company) formerly PT KIA Asia Finance, was established based on the Notarial Deed No. 44 of Maria Kristiana Soeharyo, S.H., dated February 12, 1990.
Read more on TRUS →